
Sign up to save your podcasts
Or


Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.

78,614 Listeners

32,164 Listeners

6,788 Listeners

29,054 Listeners

15,462 Listeners

2,690 Listeners

404 Listeners

2,179 Listeners

1,960 Listeners

420 Listeners

12,137 Listeners

17,812 Listeners

969 Listeners

112,482 Listeners

194 Listeners

30 Listeners

10,041 Listeners

4 Listeners

58 Listeners

233 Listeners

229 Listeners

65 Listeners

75 Listeners

82 Listeners

396 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

72 Listeners

1,151 Listeners

48 Listeners